Tourmaline Bio is developing targeted biologic therapies to treat immune and inflammatory diseases, focusing on establishing new standards of care for conditions with significant unmet medical needs. Their approach aims to improve patient outcomes by addressing the underlying mechanisms of these diseases through innovative therapeutic modalities.
Funding
$172.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many immune and inflammatory diseases lack targeted therapies, resulting in suboptimal treatment outcomes and significant unmet medical needs for affected individuals. Current treatments often fail to address the underlying mechanisms of these diseases, leading to inadequate symptom control and disease progression.
Solution
Tourmaline Bio is developing targeted biologic therapies designed to establish new standards of care for immune and inflammatory diseases. Their approach focuses on addressing the root causes of these conditions through innovative therapeutic modalities, aiming to improve patient outcomes by precisely modulating the immune response. By targeting specific pathways involved in disease pathogenesis, Tourmaline Bio seeks to develop more effective and durable treatments with fewer off-target effects. The company's pipeline includes novel biologics engineered to selectively interact with key immune mediators, thereby restoring immune homeostasis and resolving inflammation. These therapies are designed to offer a more personalized and mechanism-based approach to managing complex immune disorders.
Target Audience
The primary target audience includes patients suffering from immune and inflammatory diseases with significant unmet medical needs, as well as the physicians who treat these conditions.
Features
- Pipeline of targeted biologic therapies for immune and inflammatory diseases.
- Focus on developing treatments that address the underlying mechanisms of disease.
- Innovative therapeutic modalities designed for improved patient outcomes.